Massachusetts Financial Services CO Adaptive Biotechnologies Corp Transaction History

Massachusetts Financial Services CO

$321 Billion
Q1 2024

A detailed history of Massachusetts Financial Services CO transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Massachusetts Financial Services CO holds 2,592,318 shares of ADPT stock, worth $9.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,592,318

Previous 2,603,500 0.43%

Holding current value

$9.36 Million

Previous $12.8 Million 34.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $32,204 - $53,673	-11,182 Reduced 0.43%	2,592,318 $8.32 Million
Q4 2023 Feb 08, 2024	BUY	$3.46 - $5.33 $2.19 Million - $3.37 Million	632,040 Added 32.06%	2,603,500 $12.8 Million
Q3 2023 Nov 08, 2023	SELL	$5.07 - $8.44 $751,115 - $1.25 Million	-148,149 Reduced 6.99%	1,971,460 $10.7 Million
Q2 2023 Aug 09, 2023	SELL	$6.19 - $8.78 $987,930 - $1.4 Million	-159,601 Reduced 7.0%	2,119,609 $14.2 Million
Q1 2023 May 10, 2023	BUY	$7.8 - $10.11 $7.21 Million - $9.35 Million	924,777 Added 68.28%	2,279,210 $20.1 Million

Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $879,642 - $1.31 Million	140,518 Added 11.58%	1,354,433 $10.3 Million
Q3 2022 Nov 09, 2022	BUY	$6.5 - $12.67 $2.41 Million - $4.7 Million	370,839 Added 43.99%	1,213,915 $8.64 Million
Q2 2022 Aug 09, 2022	SELL	$6.4 - $14.73 $13 Million - $30 Million	-2,034,767 Reduced 70.7%	843,076 $6.82 Million
Q1 2022 May 11, 2022	BUY	$10.12 - $28.9 $4.55 Million - $13 Million	449,383 Added 18.5%	2,877,843 $39.9 Million
Q4 2021 Feb 10, 2022	BUY	$25.17 - $36.85 $5.28 Million - $7.73 Million	209,731 Added 9.45%	2,428,460 $68.1 Million
Q3 2021 Nov 10, 2021	BUY	$30.02 - $39.87 $2.11 Million - $2.81 Million	70,410 Added 3.28%	2,218,729 $75.4 Million
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $3.4 Million - $4.71 Million	-105,629 Reduced 4.69%	2,148,319 $87.8 Million
Q1 2021 May 13, 2021	SELL	$37.26 - $67.74 $23.9 Million - $43.4 Million	-641,296 Reduced 22.15%	2,253,948 $90.7 Million
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $2.57 Million - $3.74 Million	-57,060 Reduced 1.93%	2,895,244 $171 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $25.5 Million - $34.8 Million	713,320 Added 31.86%	2,952,304 $144 Million
Q2 2020 Aug 11, 2020	BUY	$24.95 - $48.38 $18.7 Million - $36.3 Million	750,327 Added 50.4%	2,238,984 $108 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $7.07 Million - $14.2 Million	416,712 Added 38.87%	1,488,657 $41.4 Million
Q4 2019 Feb 13, 2020	BUY	$24.56 - $32.8 $13.2 Million - $17.6 Million	535,571 Added 99.85%	1,071,945 $32.1 Million
Q3 2019 Nov 05, 2019	SELL	$30.31 - $53.51 $2.69 Million - $4.74 Million	-88,626 Reduced 14.18%	536,374 $16.6 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $25.2 Million - $30.2 Million	625,000 New	625,000 $30.2 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

2.6K

Put Options Held

143K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $516M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Adaptive Biotechnologies Corp Transaction History